Compare CDNA & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | NUTX |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 712.2M | 729.5M |
| IPO Year | 2014 | N/A |
| Metric | CDNA | NUTX |
|---|---|---|
| Price | $20.58 | $184.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $26.00 | ★ $252.50 |
| AVG Volume (30 Days) | ★ 816.3K | 225.2K |
| Earning Date | 11-04-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 1.22 | ★ 17.98 |
| Revenue | $357,998,000.00 | ★ $981,195,633.00 |
| Revenue This Year | $14.11 | $104.36 |
| Revenue Next Year | $12.00 | $4.10 |
| P/E Ratio | $16.92 | ★ $10.29 |
| Revenue Growth | 14.46 | ★ 236.03 |
| 52 Week Low | $10.96 | $28.12 |
| 52 Week High | $25.95 | $193.00 |
| Indicator | CDNA | NUTX |
|---|---|---|
| Relative Strength Index (RSI) | 71.98 | 66.64 |
| Support Level | $18.36 | $107.09 |
| Resistance Level | $19.95 | $187.20 |
| Average True Range (ATR) | 0.86 | 15.93 |
| MACD | 0.19 | 5.80 |
| Stochastic Oscillator | 99.42 | 87.38 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.